New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioCardia, Inc.
BCDA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

12M

Biotechnology

Next Earning date - 26 Mar 2025

12M

Biotechnology

Next Earning date - 26 Mar 2025

2.12USD

Shape0.07 ( 3.17%)
moonAfter-hours 2.54$arrow-right-up0.00 (0.00%)
Market Closed (as of Feb 26, 15:29 EDT)
favorite-chart

Relative Strenght

61
favorite-chart

Volume Buzz

-85%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated March 13, 2025
1W -1.91 % 1M -9.51 % 3M 22.97 % 1Y -56.44 %

Key Metrics

Shape
  • Market Cap

    11.78M


  • Shares Outstanding

    4.58M


  • Share in Float

    3.62M


  • Dividende

    0


  • Earning Date

    26 Mar 2025


  • Price Target

    2.57


  • Average Volume

    53758


  • Beta

    1.279


  • Range

    1.63-6.45


  • Industry

    Biotechnology


  • Website

    https://www.biocardia.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

165.94x

P/S Ratio

2.64x

P/B Ratio

0.4

Debt/Equity

-10876.1%

Net Margin

$-4.0

EPS

How BCDA compares to sector?

P/E Ratio

Relative Strength

Shape

BCDA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$50K

ShapeNaN%

2025-Revenue

$1.31

Shape-115%

2025-EPS

$50K

Shape97%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Dawson James

downgrade

Previous: Not converted

2022-11-11

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-2.55
vs -2.40

Q4.22

arrow
arrow

N/A

-2.40
vs -3.15

Q1.23

arrow
arrow

N/A

-2.55
vs -2.85

Q2.23

arrow
arrow

N/A

-2.55
vs -2.10

Q3.23

arrow
arrow

N/A

-1.80
vs -2.55

Q4.23

arrow
arrow

N/A

-1.35
vs -2.40

Q1.24

arrow
arrow

N/A

-1.35
vs -2.55

Q2.24

arrow
arrow

N/A

-0.88
vs -2.55

Q3.24

arrow
arrow

N/A

-0.61
vs -1.80

Q4.24

arrow
arrow

N/A

-0.63
vs -1.35

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-74%

212K  vs 821K

Q4.22

arrow
arrow

+34%

106K  vs 79K

Q1.23

arrow
arrow

+7%

64K  vs 60K

Q2.23

arrow
arrow

-96%

43K  vs 974K

Q3.23

arrow
arrow

+68%

357K  vs 212K

Q4.23

arrow
arrow

-88%

13K  vs 106K

Q1.24

arrow
arrow

-14%

55K  vs 64K

Q2.24

arrow
arrow

-93%

3K  vs 43K

Q3.24

arrow
arrow

-100%

NA  vs 357K

Q4.24

arrow
arrow

+73%

22.5K  vs 13K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-62%

-0.62
vs -0.75

Q1.23

arrow
arrow

-184%

-1.84
vs -0.62

Q2.23

arrow
arrow

-209%

-2.09
vs -1.84

Q3.23

arrow
arrow

+390%

3.9
vs -2.09

Q4.23

arrow
arrow

+129%

1.29
vs 3.9

Q1.24

arrow
arrow

+100%

1
vs 1.29

Q2.24

arrow
arrow

+84%

0.84
vs 1

Q3.24

arrow
arrow

-63%

-0.63
vs 0.84

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

25

25
vs 26

-4%

Q4.22

arrow
arrow

28

28
vs 25

12%

Q1.23

arrow
arrow

26

26
vs 28

-7%

Q2.23

arrow
arrow

26

26
vs 26

NA

Q3.23

arrow
arrow

18

18
vs 26

-31%

Q4.23

arrow
arrow

25

25
vs 18

39%

Q1.24

arrow
arrow

22

22
vs 25

-12%

Q2.24

arrow
arrow

1

1
vs 22

-95%

Earnings Growth

Latest News